HIMS – High Tight Flag at $31. Peptide LIFE IS COMING!Hims & Hers Health, Inc. Class ABATS:HIMSkunal00This stock has been hit hard more times than I can count. And every single time the market wrote it off, it got back up. Now it's sitting on one of the cleanest high tight flag setups I've seen on this name and the fundamental story underneath it just got a whole lot stronger. $31 is the level. Clear it and hold it and this has real room to run. ───────────────────────────────── WHY THE STORY JUST CHANGED ───────────────────────────────── Three things happened in the last week that matter. First — RFK Jr. announced the FDA is going back to review 12 peptides that were placed on a restricted list back in 2023. If those restrictions get eased, HIMS is one of the most direct beneficiaries in the market. They quietly bought a peptide manufacturing facility in California last year. They already have the production capacity sitting there ready to go. That's not luck, that's positioning. Second — HIMS settled its legal battle with Novo Nordisk and signed a distribution partnership with them for Wegovy. That removes the biggest overhang on the stock and gives them a legitimate lane in the branded GLP-1 market. Management is projecting Wegovy prescriptions could exceed 100,000 per month. Third — JP Morgan initiated coverage this morning with an Overweight rating. They cited the Novo Nordisk partnership, the peptide regulatory path, and a second half revenue rebound as their "compelling catalyst path." That's fresh institutional sponsorship hitting the tape right now. The business underneath all of this is real. Full year 2025 revenue was $2.35 billion, up 59%. Over 2.5 million active subscribers. This isn't a story stock with no cash — it's a growing telehealth platform sitting on a high tight flag at a key breakout level. ───────────────────────────────── THE SETUP ───────────────────────────────── High tight flag. One of the strongest continuation patterns there is. Stock ran almost 50% in five sessions off the FDA and Novo news, then pulled back tight and is coiling right under $31. Ideally I want one more day — maybe Monday — for this to tighten up further before it breaks. Another inside day or small pullback here makes the entry even cleaner. But if $31 clears today with volume and holds, I'm not sitting on my hands waiting. ───────────────────────────────── TRADE PLAN ───────────────────────────────── Entry: Break and hold above $31 on volume Stop: Below the 20 EMA Pattern: High tight flag Prefer: One more tight day before entry but will take it today if it triggers clean ───────────────────────────────── THE RISK ───────────────────────────────── The market is frothy. We are extended and a 2-3% pullback on the broader market is overdue. If the QQQ rolls over hard, even the cleanest setups get dragged down. Manage size accordingly. The setup is there — the market environment is the wildcard.